-
1
-
-
0023148154
-
Fixed drug eruption to naproxen
-
Habbema L, Bruynzeel DP. Fixed drug eruption to naproxen. Dermatologica 1987; 174: 184-5.
-
(1987)
Dermatologica
, vol.174
, pp. 184-185
-
-
Habbema, L.1
Bruynzeel, D.P.2
-
3
-
-
0035725064
-
Fixed drug eruption due to naproxen: Lack of cross-reactivity with other propionic acid derivatives
-
Gonzalo MA, Alvarado MI, Fernández L et al. Fixed drug eruption due to naproxen: lack of cross-reactivity with other propionic acid derivatives. Br J Dermatol 2001; 144: 1291-2.
-
(2001)
Br J Dermatol
, vol.144
, pp. 1291-1292
-
-
Gonzalo, M.A.1
Alvarado, M.I.2
Fernández, L.3
-
5
-
-
0036592702
-
Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing
-
Zedlitz S, Linzbach L, Kaufmann R, Boehncke WH. Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing. Contact Dermatitis 2002; 46: 352-3.
-
(2002)
Contact Dermatitis
, vol.46
, pp. 352-353
-
-
Zedlitz, S.1
Linzbach, L.2
Kaufmann, R.3
Boehncke, W.H.4
-
8
-
-
0028360096
-
Topical provocation of fixed drug eruption
-
Alanko K. Topical provocation of fixed drug eruption. Contact Dermatitis 1994; 31: 25-7.
-
(1994)
Contact Dermatitis
, vol.31
, pp. 25-27
-
-
Alanko, K.1
-
9
-
-
0035788784
-
Current causes of fixed drug eruption in the UK
-
Savin JA. Current causes of fixed drug eruption in the UK. Br J Dermatol 2001; 145: 667-8.
-
(2001)
Br J Dermatol
, vol.145
, pp. 667-668
-
-
Savin, J.A.1
-
10
-
-
0023109293
-
Topical provocation of fixed drug eruption
-
Alanko K, Stubb S, Reitamo S. Topical provocation of fixed drug eruption. Br J Dermatol 1987; 116: 561-7.
-
(1987)
Br J Dermatol
, vol.116
, pp. 561-567
-
-
Alanko, K.1
Stubb, S.2
Reitamo, S.3
-
11
-
-
0032886643
-
Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption
-
Ozkaya-Bayazit E, Bayazit H, Ozarmagan G. Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption. Contact Dermatitis 1999; 41: 185-9.
-
(1999)
Contact Dermatitis
, vol.41
, pp. 185-189
-
-
Ozkaya-Bayazit, E.1
Bayazit, H.2
Ozarmagan, G.3
-
12
-
-
0344430227
-
Specific site involvement in fixed drug eruption
-
Ozkaya-Bayazit E. Specific site involvement in fixed drug eruption. J Am Acad Dermatol 2003; 49: 1003-7.
-
(2003)
J Am Acad Dermatol
, vol.49
, pp. 1003-1007
-
-
Ozkaya-Bayazit, E.1
-
13
-
-
0036091864
-
Peculiar unilateral fixed drug eruption of the breast
-
Li H, Wiederkehr M, Rao Bk et al. Peculiar unilateral fixed drug eruption of the breast. Int J Dermatol 2002; 41: 96-8.
-
(2002)
Int J Dermatol
, vol.41
, pp. 96-98
-
-
Li, H.1
Wiederkehr, M.2
Rao, Bk.3
-
14
-
-
0030160439
-
Dermacase. Fixed drug eruption
-
Enta T. Dermacase. Fixed drug eruption. Can Fam Physician 1996; 42: 1099-101.
-
(1996)
Can Fam Physician
, vol.42
, pp. 1099-1101
-
-
Enta, T.1
-
15
-
-
0021136133
-
An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs
-
Stern RS, Bigby M. An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs. JAMA 1984; 252: 1433-7.
-
(1984)
JAMA
, vol.252
, pp. 1433-1437
-
-
Stern, R.S.1
Bigby, M.2
-
16
-
-
0001361886
-
Topical pharmacology and toxicology of dimethyl sulphoxide. Part 1
-
Kligman AM. Topical pharmacology and toxicology of dimethyl sulphoxide. Part 1. JAMA 1965; 193: 796-804.
-
(1965)
JAMA
, vol.193
, pp. 796-804
-
-
Kligman, A.M.1
|